000 03659nam a22003015i 4500
001 402588
003 ES-MaUEC
005 20240528105912.0
007 cr nn 008mamaa
008 230621s2023 sz | o |||| 0|eng d
020 _a9783031280610
024 7 _a10.1007/978-3-031-28061-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC952-954.6
_b2023 EB
245 0 0 _aOptimizing Pharmacotherapy in Older Patients :
_bAn Interdisciplinary Approach
_cedited by Antonio Cherubini, Arduino A Mangoni, Denis O'Mahony, Mirko Petrovic
250 _a1st ed. 2023
264 1 _aCham
_bSpringer International Publishing
_c2023
300 _a1 recurso en línea
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aPractical Issues in Geriatrics
_x2509-6079
505 0 _aSection 1: General issues -- 1. The impact of ageing on pharmacokinetics -- 2. Polypharmacy: Definition, Epidemiology, Consequences and Solutions -- 3. Drug-Drug and Drug-Nutrients Interactions: From Theory to Clinical Relevance -- 4. Inappropriate Prescription of Medicines -- 5. Prescribing Cascades -- 6. Adverse Drug Reactions in Older People: a 21st Century View -- 7. Adherence: How to Measure and Improve It -- 8. Medication reconciliation and review: theory, practice and evidence -- 9. The role of pharmacists in optimizing drug therapy -- 10. Deprescribing: Evidence base and implementation -- Section 2: Geriatric syndromes and common chronic conditions -- 11. General principles of management of patients with multimorbidity and frailty -- 12. Frailty and Drug Therapy -- 13. Falls and Impaired mobility -- 14. Delirium -- 15. Incontinence -- 16. Constipation -- 17. Pain -- 18. Hypertension -- 19. Heart Failure -- 20. Pharmacological treatment of cognitive and behavioral disorders in dementia -- 21. Pharmacological treatment of osteoporosis in older patients -- 22. Chronic respiratory disease: COPD, IPF -- 23. Diabetes -- 24. Stroke therapeutics in the care of older persons -- 25. Optimizing pharmacotherapy in older patients with depression or anxiety -- 26. Nutritional Deficiency and Malnutrition -- 27. Pharmacotherapy of Insomnia in older adults -- 28. Chronic kidney disease -- 29. Palliation at End of Life.
520 _aThis book summarizes the broad and rapidly evolving field of geriatric pharmacotherapy, which is becoming increasingly relevant for practicing physicians who care and prescribe medications for older patients. Around the globe, ageing populations are associated with an increased prevalence of chronic diseases. Older adults are often affected by multimorbidity, i.e., suffer from more than one chronic disease. The main consequence of multimorbidity is polypharmacy, which is commonly defined as the regular use of five or more medicines. Polypharmacy has now reached epidemic proportions in our societies, and is associated with an increased risk of drug-drug interactions, drug-disease interactions and adverse drug reactions. The management of polypharmacy in older patients with complex multimorbidity poses several challenges and needs to be based on specific knowledge and prescribing expertise. The aim of this book is to provide a comprehensive update on thefield, and to share the expertise needed to optimize the management of pharmacotherapy in older patients.
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-28061-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
988 _aSpringer_Medicine_2023
999 _c402588
_d402588